Not surprised. Not suspicious.
This is science. This is innovation.
It is complex and moving rapidly. It is not a straight path and there are likely to be many more surprising turns of events yet.
People are really underestimating the complexities of getting vaccine to everyone.
We (UK) and the whole world are extremely reliant on the Oxford vaccine at the moment (and other similar ones if they prove effective).
If we can’t figure out a way to get the highly effective RNA vaccines to specific subset of our population in defined spaces, what chance have developing countries got?
There are going to need to be some massive advances and innovations in materials science and engineering to allow improved stability and hyper cold chain distribution globally.
Yes, by the way, the Moderna vaccine has huge advantages over Pfizer when it comes to stability. But is still a massive challenge.
Both companies are going to have to re-engineer their vaccines to improve stability and re run clinical trials to make sure new formulations are just as efficacious.
The National vaccination strategy for a vaccine that is 63% effective (Oxford/Astra Zeneca) is very different than the strategy for a 90% effective vaccine (Moderna and Pfizer).
I’m not sure we won’t see some changes to the plans for care home vaccination now.. we wait with baited breath for the extension and further results of the Astra Zeneca trial.